Skip to content

Can we successfully deliver and evaluate a physiotherapist-led behaviour-change programme to support walking in people with intermittent claudication? A feasibility and acceptability study

A randomised controlled trial of a physiotherapist-led behaviour-change intervention targeting walking in people with intermittent claudication: a feasibility and acceptability study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55465549
Enrollment
24
Registered
2014-06-05
Start date
2014-04-03
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent claudication due to peripheral vascular disease. Circulatory System

Interventions

1. Treatment: Brief home-based physiotherapist-led behaviour-change intervention targeting walking activity and using the following behaviour change techniques: social support, information about healt

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age =18 years 2. Peripheral arterial disease and intermittent claudication as established by a vascular clinician, and based on arterial palpitation, or results of angiography, computed tomography, or MRI scanning.

Exclusion criteria

Exclusion criteria: 1. Presence of a condition for which it is unadvisable to increase walking (e.g., unstable angina) 2. Endovascular treatment or bypass surgery scheduled in the upcoming 4 months 3. Comorbidity which limits walking to a greater extent than intermittent claudication 4. Inability or refusal to provide informed consent 5. Inability to comprehend English

Design outcomes

Primary

MeasureTime frame
1. Change in 6-Minute Walk Distance (metres) at 16-week follow-up, measured by a 6-Minute Walk Test; 2. Change in pedometer Step Count (average steps/day) at 16-week follow-up, measured using an Omron Walking Style Pro.

Secondary

MeasureTime frame
1. Change in treatment cognitions measured by a Theory of Planned Behaviour Questionnaire at 16-week follow-up 2. Change in illness cognitions measured by the Revised Illness Perceptions Questionnaire at 16-week follow-up 3. Change in self-regulatory processes measured by a modified questionnaire on Action Planning and Action Control at 16-week follow-up

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026